APO Research
Talk to an analyst

APO RESEARCH · REPORT

Post herpetic Neuralgia Treatment

Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for post herpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antiviral agents.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for post herpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antiviral agents.

Selected research

Market Structure

Global Post herpetic Neuralgia Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025182 pages

Choose your research edition.

Industry ResearchPost herpetic Neuralgia Treatment Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Post herpetic Neuralgia Treatment Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Post herpetic Neuralgia Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Post herpetic Neuralgia Treatment Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Post herpetic Neuralgia Treatment Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for post herpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antiviral agents.

Global Post herpetic Neuralgia Treatment key players include Pfizer, Arbor Pharma, Assertio Therapeutics, Endo Pharma, Teikoku Pharma, etc. Global top five manufacturers hold a share about 80%.

North America is the largest market, with a share over 50%, followed by Europe and China, both have a share about 30 percent.

Read the full market overview

In terms of product, Anticonvulsants is the largest segment, with a share over 80%. And in terms of distribution channel, the largest distribution channel is Hospital Pharmacies, followed by Retail Pharmacies.

Report Includes

This report provides an overview of the global Post herpetic Neuralgia Treatment market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Post herpetic Neuralgia Treatment and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Post herpetic Neuralgia Treatment revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Post herpetic Neuralgia Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

Post herpetic Neuralgia Treatment Segment by Company

Pfizer

Arbor Pharma

Assertio Therapeutics

Endo Pharma

Teikoku Pharma

Teva

Mylan

Hengrui Medicine

Post herpetic Neuralgia Treatment Segment by Type

Anticonvulsants

Skin Patch

Other

Post herpetic Neuralgia Treatment Segment by Distribution Channel

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Post herpetic Neuralgia Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Post herpetic Neuralgia Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Post herpetic Neuralgia Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Post herpetic Neuralgia Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Post herpetic Neuralgia Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Post herpetic Neuralgia Treatment industry.

Chapter 3: Detailed analysis of Post herpetic Neuralgia Treatment companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Post herpetic Neuralgia Treatmentrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Post herpetic Neuralgia Treatment Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Anticonvulsants Table 3. Key Players of Skin Patch Table 4. Key Players of Other Table 4. Global Post herpetic Neuralgia Treatment Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Pharmacies Table 6. Key Players of Online Pharmacies Table 7. Key Players of Retail Pharmacies Table 8. Global Post herpetic Neuralgia Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Post herpetic Neuralgia Treatment Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Post herpetic Neuralgia Treatment Market Share by Region (2021-2026) Table 11. Global Post herpetic Neuralgia Treatment Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Post herpetic Neuralgia Treatment Market Share by Region (2027-2032) Table 13. Post herpetic Neuralgia Treatment Industry Trends Table 14. Post herpetic Neuralgia Treatment Industry Drivers Table 15. Post herpetic Neuralgia Treatment Industry Opportunities and Challenges Table 16. Post herpetic Neuralgia Treatment Industry Restraints Table 17. Global Post herpetic Neuralgia Treatment Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Post herpetic Neuralgia Treatment Revenue Market Share by Company (2021-2026) Table 19. Global Post herpetic Neuralgia Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Post herpetic Neuralgia Treatment Key Company Head Office and Area Served Table 21. Global Post herpetic Neuralgia Treatment Company, Product Type & Application Table 22. Global Post herpetic Neuralgia Treatment Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Post herpetic Neuralgia Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Post herpetic Neuralgia Treatment Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Post herpetic Neuralgia Treatment Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Post herpetic Neuralgia Treatment Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Post herpetic Neuralgia Treatment Revenue Market Share by Type (2021-2026) Table 29. Global Post herpetic Neuralgia Treatment Revenue Market Share by Type (2027-2032) Table 30. Global Post herpetic Neuralgia Treatment Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Post herpetic Neuralgia Treatment Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Post herpetic Neuralgia Treatment Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Post herpetic Neuralgia Treatment Revenue Market Share by Application (2021-2026) Table 34. Global Post herpetic Neuralgia Treatment Revenue Market Share by Application (2027-2032) Table 35. Pfizer Company Information Table 36. Pfizer Business Overview Table 37. Pfizer Post herpetic Neuralgia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Pfizer Post herpetic Neuralgia Treatment Product Portfolio Table 39. Pfizer Recent Development Table 40. Arbor Pharma Company Information Table 41. Arbor Pharma Business Overview Table 42. Arbor Pharma Post herpetic Neuralgia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Arbor Pharma Post herpetic Neuralgia Treatment Product Portfolio Table 44. Arbor Pharma Recent Development Table 45. Assertio Therapeutics Company Information Table 46. Assertio Therapeutics Business Overview Table 47. Assertio Therapeutics Post herpetic Neuralgia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Assertio Therapeutics Post herpetic Neuralgia Treatment Product Portfolio Table 49. Assertio Therapeutics Recent Development Table 50. Endo Pharma Company Information Table 51. Endo Pharma Business Overview Table 52. Endo Pharma Post herpetic Neuralgia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Endo Pharma Post herpetic Neuralgia Treatment Product Portfolio Table 54. Endo Pharma Recent Development Table 55. Teikoku Pharma Company Information Table 56. Teikoku Pharma Business Overview Table 57. Teikoku Pharma Post herpetic Neuralgia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Teikoku Pharma Post herpetic Neuralgia Treatment Product Portfolio Table 59. Teikoku Pharma Recent Development Table 60. Teva Company Information Table 61. Teva Business Overview Table 62. Teva Post herpetic Neuralgia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Teva Post herpetic Neuralgia Treatment Product Portfolio Table 64. Teva Recent Development Table 65. Mylan Company Information Table 66. Mylan Business Overview Table 67. Mylan Post herpetic Neuralgia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Mylan Post herpetic Neuralgia Treatment Product Portfolio Table 69. Mylan Recent Development Table 70. Hengrui Medicine Company Information Table 71. Hengrui Medicine Business Overview Table 72. Hengrui Medicine Post herpetic Neuralgia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Hengrui Medicine Post herpetic Neuralgia Treatment Product Portfolio Table 74. Hengrui Medicine Recent Development Table 75. North America Post herpetic Neuralgia Treatment Market Size by Type (2021-2026) & (US$ Million) Table 76. North America Post herpetic Neuralgia Treatment Market Size by Type (2027-2032) & (US$ Million) Table 77. North America Post herpetic Neuralgia Treatment Market Size by Application (2021-2026) & (US$ Million) Table 78. North America Post herpetic Neuralgia Treatment Market Size by Application (2027-2032) & (US$ Million) Table 79. North America Post herpetic Neuralgia Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 80. North America Post herpetic Neuralgia Treatment Market Size by Country (2021-2026) Table 81. North America Post herpetic Neuralgia Treatment Market Size by Country (2027-2032) Table 82. Europe Post herpetic Neuralgia Treatment Market Size by Type (2021-2026) & (US$ Million) Table 83. Europe Post herpetic Neuralgia Treatment Market Size by Type (2027-2032) & (US$ Million) Table 84. Europe Post herpetic Neuralgia Treatment Market Size by Application (2021-2026) & (US$ Million) Table 85. Europe Post herpetic Neuralgia Treatment Market Size by Application (2027-2032) & (US$ Million) Table 86. Europe Post herpetic Neuralgia Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 87. Europe Post herpetic Neuralgia Treatment Market Size by Country (2021-2026) Table 88. Europe Post herpetic Neuralgia Treatment Market Size by Country (2027-2032) Table 89. China Post herpetic Neuralgia Treatment Market Size by Type (2021-2026) & (US$ Million) Table 90. China Post herpetic Neuralgia Treatment Market Size by Type (2027-2032) & (US$ Million) Table 91. China Post herpetic Neuralgia Treatment Market Size by Application (2021-2026) & (US$ Million) Table 92. China Post herpetic Neuralgia Treatment Market Size by Application (2027-2032) & (US$ Million) Table 93. Asia Post herpetic Neuralgia Treatment Market Size by Type (2021-2026) & (US$ Million) Table 94. Asia Post herpetic Neuralgia Treatment Market Size by Type (2027-2032) & (US$ Million) Table 95. Asia Post herpetic Neuralgia Treatment Market Size by Application (2021-2026) & (US$ Million) Table 96. Asia Post herpetic Neuralgia Treatment Market Size by Application (2027-2032) & (US$ Million) Table 97. Asia Post herpetic Neuralgia Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Asia Post herpetic Neuralgia Treatment Market Size by Country (2021-2026) Table 99. Asia Post herpetic Neuralgia Treatment Market Size by Country (2027-2032) Table 100. South America, Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Type (2021-2026) & (US$ Million) Table 101. South America, Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Type (2027-2032) & (US$ Million) Table 102. South America, Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Application (2021-2026) & (US$ Million) Table 103. South America, Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Application (2027-2032) & (US$ Million) Table 104. South America, Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. South America, Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Country (2021-2026) Table 106. South America, Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Country (2027-2032) Table 107. Research Programs/Design for This Report Table 108. Authors List of This Report Table 109. Secondary Sources Table 110. Primary Sources List of Figures Figure 1. Post herpetic Neuralgia Treatment Product Image Figure 2. Global Post herpetic Neuralgia Treatment Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Post herpetic Neuralgia Treatment Market Share by Type: 2025 VS 2032 Figure 4. Anticonvulsants Image Figure 5. Skin Patch Image Figure 6. Other Image Figure 7. Global Post herpetic Neuralgia Treatment Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Post herpetic Neuralgia Treatment Market Share by Application: 2025 VS 2032 Figure 9. Hospital Pharmacies Image Figure 10. Online Pharmacies Image Figure 11. Retail Pharmacies Image Figure 12. Global Post herpetic Neuralgia Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Post herpetic Neuralgia Treatment Market Size (2021-2032) & (US$ Million) Figure 14. Global Post herpetic Neuralgia Treatment Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Post herpetic Neuralgia Treatment Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Post herpetic Neuralgia Treatment Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Post herpetic Neuralgia Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Post herpetic Neuralgia Treatment Revenue Market Share by Type (2021-2032) Figure 21. Global Post herpetic Neuralgia Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Post herpetic Neuralgia Treatment Revenue Market Share by Application (2021-2032) Figure 23. North America Post herpetic Neuralgia Treatment Market Size (2021-2032) & (US$ Million) Figure 24. North America Post herpetic Neuralgia Treatment Market Share by Type (2021-2032) Figure 25. North America Post herpetic Neuralgia Treatment Market Share by Application (2021-2032) Figure 26. North America Post herpetic Neuralgia Treatment Market Share by Country (2021-2032) Figure 27. United States Post herpetic Neuralgia Treatment Market Size (2021-2032) & (US$ Million) Figure 28. Canada Post herpetic Neuralgia Treatment Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Post herpetic Neuralgia Treatment Market Size (2021-2032) & (US$ Million) Figure 30. Europe Post herpetic Neuralgia Treatment Market Size (2021-2032) & (US$ Million) Figure 31. Europe Post herpetic Neuralgia Treatment Market Share by Type (2021-2032) Figure 32. Europe Post herpetic Neuralgia Treatment Market Share by Application (2021-2032) Figure 33. Europe Post herpetic Neuralgia Treatment Market Share by Country (2021-2032) Figure 34. Germany Post herpetic Neuralgia Treatment Market Size (2021-2032) & (US$ Million) Figure 35. France Post herpetic Neuralgia Treatment Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Post herpetic Neuralgia Treatment Market Size (2021-2032) & (US$ Million) Figure 37. Italy Post herpetic Neuralgia Treatment Market Size (2021-2032) & (US$ Million) Figure 38. Russia Post herpetic Neuralgia Treatment Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Post herpetic Neuralgia Treatment Market Size (2021-2032) & (US$ Million) Figure 40. China Post herpetic Neuralgia Treatment Market Size (2021-2032) & (US$ Million) Figure 41. China Post herpetic Neuralgia Treatment Market Share by Type (2021-2032) Figure 42. China Post herpetic Neuralgia Treatment Market Share by Application (2021-2032) Figure 43. Asia Post herpetic Neuralgia Treatment Market Size (2021-2032) & (US$ Million) Figure 44. Asia Post herpetic Neuralgia Treatment Market Share by Type (2021-2032) Figure 45. Asia Post herpetic Neuralgia Treatment Market Share by Application (2021-2032) Figure 46. Asia Post herpetic Neuralgia Treatment Market Share by Country (2021-2032) Figure 47. Japan Post herpetic Neuralgia Treatment Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Post herpetic Neuralgia Treatment Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Post herpetic Neuralgia Treatment Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Post herpetic Neuralgia Treatment Market Size (2021-2032) & (US$ Million) Figure 51. India Post herpetic Neuralgia Treatment Market Size (2021-2032) & (US$ Million) Figure 52. Australia Post herpetic Neuralgia Treatment Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Post herpetic Neuralgia Treatment Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Post herpetic Neuralgia Treatment Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Post herpetic Neuralgia Treatment Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Post herpetic Neuralgia Treatment Market Share by Country (2021-2032) Figure 57. Brazil Post herpetic Neuralgia Treatment Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Post herpetic Neuralgia Treatment Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Post herpetic Neuralgia Treatment Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Post herpetic Neuralgia Treatment Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Post herpetic Neuralgia Treatment Market Size (2021-2032) & (US$ Million) Figure 62. UAE Post herpetic Neuralgia Treatment Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Post herpetic Neuralgia Treatment Market Size (2021-2032) & (US$ Million) Figure 64. Chile Post herpetic Neuralgia Treatment Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Anticonvulsants
  • Skin Patch
  • Other
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Pfizer
  • Arbor Pharma
  • Assertio Therapeutics
  • Endo Pharma
  • Teikoku Pharma
  • Teva
  • Mylan
  • Hengrui Medicine

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Post herpetic Neuralgia Treatment Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Anticonvulsants
  5. 1.2.3 Skin Patch
  6. 1.2.4 Other
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Post herpetic Neuralgia Treatment Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital Pharmacies
  10. 1.3.3 Online Pharmacies
  11. 1.3.4 Retail Pharmacies
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Post herpetic Neuralgia Treatment Growth Trends by Region
  14. 1.5.1 Global Post herpetic Neuralgia Treatment Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Post herpetic Neuralgia Treatment Market Size by Region (2021-2026)
  16. 1.5.3 Post herpetic Neuralgia Treatment Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Post herpetic Neuralgia Treatment Market Dynamics
  1. 2.1 Post herpetic Neuralgia Treatment Industry Trends
  2. 2.2 Post herpetic Neuralgia Treatment Industry Drivers
  3. 2.3 Post herpetic Neuralgia Treatment Industry Opportunities and Challenges
  4. 2.4 Post herpetic Neuralgia Treatment Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Post herpetic Neuralgia Treatment Revenue by Company (2021-2026)
  2. 3.2 Global Post herpetic Neuralgia Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Post herpetic Neuralgia Treatment Key Company Head office and Area Served
  4. 3.4 Global Post herpetic Neuralgia Treatment Company, Product Type & Application
  5. 3.5 Global Post herpetic Neuralgia Treatment Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Post herpetic Neuralgia Treatment Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Post herpetic Neuralgia Treatment Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Post herpetic Neuralgia Treatment Tier 1, Tier 2, and Tier 3
4 Post herpetic Neuralgia Treatment Market by Type
  1. 4.1 Global Post herpetic Neuralgia Treatment Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Post herpetic Neuralgia Treatment Market Size by Type (2021-2032)
  3. 4.3 Global Post herpetic Neuralgia Treatment Market Size Share by Type (2021-2032)
5 Post herpetic Neuralgia Treatment Market by Application
  1. 5.1 Global Post herpetic Neuralgia Treatment Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Post herpetic Neuralgia Treatment Market Size by Application (2021-2032)
  3. 5.3 Global Post herpetic Neuralgia Treatment Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Pfizer
  2. 6.1.1 Pfizer Company Information
  3. 6.1.2 Pfizer Business Overview
  4. 6.1.3 Pfizer Post herpetic Neuralgia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Pfizer Post herpetic Neuralgia Treatment Product Portfolio
  6. 6.1.5 Pfizer Recent Developments
  7. 6.2 Arbor Pharma
  8. 6.2.1 Arbor Pharma Company Information
  9. 6.2.2 Arbor Pharma Business Overview
  10. 6.2.3 Arbor Pharma Post herpetic Neuralgia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Arbor Pharma Post herpetic Neuralgia Treatment Product Portfolio
  12. 6.2.5 Arbor Pharma Recent Developments
  13. 6.3 Assertio Therapeutics
  14. 6.3.1 Assertio Therapeutics Company Information
  15. 6.3.2 Assertio Therapeutics Business Overview
  16. 6.3.3 Assertio Therapeutics Post herpetic Neuralgia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Assertio Therapeutics Post herpetic Neuralgia Treatment Product Portfolio
  18. 6.3.5 Assertio Therapeutics Recent Developments
  19. 6.4 Endo Pharma
  20. 6.4.1 Endo Pharma Company Information
  21. 6.4.2 Endo Pharma Business Overview
  22. 6.4.3 Endo Pharma Post herpetic Neuralgia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Endo Pharma Post herpetic Neuralgia Treatment Product Portfolio
  24. 6.4.5 Endo Pharma Recent Developments
  25. 6.5 Teikoku Pharma
  26. 6.5.1 Teikoku Pharma Company Information
  27. 6.5.2 Teikoku Pharma Business Overview
  28. 6.5.3 Teikoku Pharma Post herpetic Neuralgia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Teikoku Pharma Post herpetic Neuralgia Treatment Product Portfolio
  30. 6.5.5 Teikoku Pharma Recent Developments
  31. 6.6 Teva
  32. 6.6.1 Teva Company Information
  33. 6.6.2 Teva Business Overview
  34. 6.6.3 Teva Post herpetic Neuralgia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Teva Post herpetic Neuralgia Treatment Product Portfolio
  36. 6.6.5 Teva Recent Developments
  37. 6.7 Mylan
  38. 6.7.1 Mylan Company Information
  39. 6.7.2 Mylan Business Overview
  40. 6.7.3 Mylan Post herpetic Neuralgia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Mylan Post herpetic Neuralgia Treatment Product Portfolio
  42. 6.7.5 Mylan Recent Developments
  43. 6.8 Hengrui Medicine
  44. 6.8.1 Hengrui Medicine Company Information
  45. 6.8.2 Hengrui Medicine Business Overview
  46. 6.8.3 Hengrui Medicine Post herpetic Neuralgia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Hengrui Medicine Post herpetic Neuralgia Treatment Product Portfolio
  48. 6.8.5 Hengrui Medicine Recent Developments
7 North America
  1. 7.1 North America Post herpetic Neuralgia Treatment Market Size (2021-2032)
  2. 7.2 North America Post herpetic Neuralgia Treatment Market Size by Type
  3. 7.2.1 North America Post herpetic Neuralgia Treatment Market Size by Type (2021-2026)
  4. 7.2.2 North America Post herpetic Neuralgia Treatment Market Size by Type (2027-2032)
  5. 7.2.3 North America Post herpetic Neuralgia Treatment Market Share by Type (2021-2032)
  6. 7.3 North America Post herpetic Neuralgia Treatment Market Size by Application
  7. 7.3.1 North America Post herpetic Neuralgia Treatment Market Size by Application (2021-2026)
  8. 7.3.2 North America Post herpetic Neuralgia Treatment Market Size by Application (2027-2032)
  9. 7.3.3 North America Post herpetic Neuralgia Treatment Market Share by Application (2021-2032)
  10. 7.4 North America Post herpetic Neuralgia Treatment Market Size by Country
  11. 7.4.1 North America Post herpetic Neuralgia Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Post herpetic Neuralgia Treatment Market Size by Country (2021-2026)
  13. 7.4.3 North America Post herpetic Neuralgia Treatment Market Size by Country (2027-2032)
  14. 7.4.4 North America Post herpetic Neuralgia Treatment Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Post herpetic Neuralgia Treatment Market Size (2021-2032)
  2. 8.2 Europe Post herpetic Neuralgia Treatment Market Size by Type
  3. 8.2.1 Europe Post herpetic Neuralgia Treatment Market Size by Type (2021-2026)
  4. 8.2.2 Europe Post herpetic Neuralgia Treatment Market Size by Type (2027-2032)
  5. 8.2.3 Europe Post herpetic Neuralgia Treatment Market Share by Type (2021-2032)
  6. 8.3 Europe Post herpetic Neuralgia Treatment Market Size by Application
  7. 8.3.1 Europe Post herpetic Neuralgia Treatment Market Size by Application (2021-2026)
  8. 8.3.2 Europe Post herpetic Neuralgia Treatment Market Size by Application (2027-2032)
  9. 8.3.3 Europe Post herpetic Neuralgia Treatment Market Share by Application (2021-2032)
  10. 8.4 Europe Post herpetic Neuralgia Treatment Market Size by Country
  11. 8.4.1 Europe Post herpetic Neuralgia Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Post herpetic Neuralgia Treatment Market Size by Country (2021-2026)
  13. 8.4.3 Europe Post herpetic Neuralgia Treatment Market Size by Country (2027-2032)
  14. 8.4.4 Europe Post herpetic Neuralgia Treatment Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Post herpetic Neuralgia Treatment Market Size (2021-2032)
  2. 9.2 China Post herpetic Neuralgia Treatment Market Size by Type
  3. 9.2.1 China Post herpetic Neuralgia Treatment Market Size by Type (2021-2026)
  4. 9.2.2 China Post herpetic Neuralgia Treatment Market Size by Type (2027-2032)
  5. 9.2.3 China Post herpetic Neuralgia Treatment Market Share by Type (2021-2032)
  6. 9.3 China Post herpetic Neuralgia Treatment Market Size by Application
  7. 9.3.1 China Post herpetic Neuralgia Treatment Market Size by Application (2021-2026)
  8. 9.3.2 China Post herpetic Neuralgia Treatment Market Size by Application (2027-2032)
  9. 9.3.3 China Post herpetic Neuralgia Treatment Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Post herpetic Neuralgia Treatment Market Size (2021-2032)
  2. 10.2 Asia Post herpetic Neuralgia Treatment Market Size by Type
  3. 10.2.1 Asia Post herpetic Neuralgia Treatment Market Size by Type (2021-2026)
  4. 10.2.2 Asia Post herpetic Neuralgia Treatment Market Size by Type (2027-2032)
  5. 10.2.3 Asia Post herpetic Neuralgia Treatment Market Share by Type (2021-2032)
  6. 10.3 Asia Post herpetic Neuralgia Treatment Market Size by Application
  7. 10.3.1 Asia Post herpetic Neuralgia Treatment Market Size by Application (2021-2026)
  8. 10.3.2 Asia Post herpetic Neuralgia Treatment Market Size by Application (2027-2032)
  9. 10.3.3 Asia Post herpetic Neuralgia Treatment Market Share by Application (2021-2032)
  10. 10.4 Asia Post herpetic Neuralgia Treatment Market Size by Country
  11. 10.4.1 Asia Post herpetic Neuralgia Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Post herpetic Neuralgia Treatment Market Size by Country (2021-2026)
  13. 10.4.3 Asia Post herpetic Neuralgia Treatment Market Size by Country (2027-2032)
  14. 10.4.4 Asia Post herpetic Neuralgia Treatment Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Post herpetic Neuralgia Treatment Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Post herpetic Neuralgia Treatment Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Post herpetic Neuralgia Treatment Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Post herpetic Neuralgia Treatment Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst